Amneal Pharmaceuticals, Inc. (AMRX) Share-based Payment Arrangement, Expense USD 2016 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Amneal Pharmaceuticals, Inc. annual/quarterly Share-based Payment Arrangement, Expense history and growth rate from 2016 to 2023.
  • Amneal Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2018 was $3.59 M.
  • Amneal Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $26.8 M, a 15.8% decline from 2022.
  • Amneal Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $31.8 M, a 12.1% increase from 2021.
  • Amneal Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $28.4 M, a 36.9% increase from 2020.
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $26.8 M -$5.03 M -15.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 $31.8 M +$3.44 M +12.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 $28.4 M +$7.66 M +36.9% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-14
2020 $20.8 M -$929 K -4.29% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-03
2019 $21.7 M +$12.8 M +145% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $8.84 M +$8.84 M Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $0 $0 Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 $0 Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.